Publications by authors named "Randy A Lieberman"

Background: Heart failure (HF) is increasing in prevalence and is a major cause of morbidity and mortality despite advances in medical and device therapy. Autonomic imbalance, with excess sympathetic activation and decreased vagal tone, is an integral component of the pathophysiology of HF.

Objectives: The INOVATE-HF (Increase of Vagal Tone in Heart Failure) trial assessed the safety and efficacy of vagal nerve stimulation (VNS) among patients with HF and a reduced ejection fraction.

View Article and Find Full Text PDF

Background: The implantable loop recorder (ILR) is a cost-effective tool with a high diagnostic yield in the evaluation of unexplained recurrent syncope. The Sleuth ILR (Transoma Medical, St. Paul MN, USA) is a new-generation ILR with wireless transmission capability approved by the Food and Drug Administration.

View Article and Find Full Text PDF

Spiking neural network (NN) architecture that uses Hebbian learning and reinforcement-learning schemes for adapting the synaptic weights is implemented in silicon and performs dynamic optimization according to hemodynamic sensor for a cardiac resynchronization therapy (CRT) device. The spiking NN architecture dynamically changes the atrioventricular (AV) delay and interventricular (VV) interval parameters according to the information provided by the intracardiac electrograms (IEGMs) and hemodynamic sensors. The spiking NN coprocessor performs the adaptive part and is controlled by a deterministic algorithm master controller.

View Article and Find Full Text PDF

Purpose: Reduced lead diameter and reliability can be designed into transvenous permanent pacing leads through use of redundant insulation and removal of the stylet lumen. The model 3830 lead (Medtronic Inc., Minneapolis, MN, USA) is a bipolar, fixed-screw, steroid-eluting, lumenless, 4.

View Article and Find Full Text PDF